Health Care Shares Move Higher as Focus Shifts to Earnings -- Health Care Roundup
10 Julio 2018 - 4:28PM
Noticias Dow Jones
Health-care shares were higher as focus shifts to the beginning
of earnings season. Celgene shares rose after the company reported
positive results from a late-stage trial of a treatment for breast
cancer, saying the trial met its co-primary endpoint of
progression-free survival. In addition, on Monday evening Celgene
and Acceleron Pharma reported positive results from a phase 3 trial
of their drug Luspatercept, a drug to treat chronic anemia,
beta-thalassemia and myelofibrosis.
Write to Amy Pessetto at amy.pessetto@dowjones.com
(END) Dow Jones Newswires
July 10, 2018 17:13 ET (21:13 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
Acceleron Pharma (NASDAQ:XLRN)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Acceleron Pharma (NASDAQ:XLRN)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024
Real-Time news about Acceleron Pharma Inc (NASDAQ): 0 recent articles
Más de Acceleron Pharma Inc. Artículos de Noticias